InsiderClue
Insiders · Profile

KANZER STEVE H

10% owner at Theriva Biologics · Director at SOLIGENIX. Filing since 31 Oct 2006. CIK 0001076653

TOVX Theriva Biologics, Inc. 10% owner · 14 trades SNGX SOLIGENIX, INC. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
TOVX Theriva Biologics, Inc.
30 Apr 2014
10% owner
Sold, plan not stated
5,003,025
$7.15M
69.5%
TOVX Theriva Biologics, Inc.
29 Apr 2014
10% owner
Sold, plan not stated
87,935
$262.05K
1.3%
TOVX Theriva Biologics, Inc.
28 Apr 2014
10% owner
Sold, plan not stated
175,177
$501.01K
2.5%
TOVX Theriva Biologics, Inc.
11 Apr 2008
Chief Executive Officer
Bought
50,000
$44.43K
15.4%
TOVX Theriva Biologics, Inc.
25 Jul 2007
CEO
Bought
14,300
$103.28K
4.6%
TOVX Theriva Biologics, Inc.
24 Jul 2007
CEO
Bought
8,000
$57.03K
2.6%
TOVX Theriva Biologics, Inc.
23 Jul 2007
CEO
Bought
29,700
$200.35K
10.9%
TOVX Theriva Biologics, Inc.
17 Jul 2007
CEO
Bought
25,000
$131.17K
10.1%
TOVX Theriva Biologics, Inc.
16 Jul 2007
CEO
Bought
81,000
$391.96K
48.4%
TOVX Theriva Biologics, Inc.
11 May 2007
Chief Executive Officer
Bought
26,500
$140.35K
6.3%
TOVX Theriva Biologics, Inc.
17 Apr 2007
Chief Executive Officer
Bought
66,000
$133.64K
18.5%
TOVX Theriva Biologics, Inc.
16 Apr 2007
Chief Executive Officer
Bought
161,000
$311.94K
82.5%
SNGX SOLIGENIX, INC.
9 Feb 2007
Director
Bought
212,766
$100.00K
19.9%
TOVX Theriva Biologics, Inc.
2 Nov 2006
CEO
Bought
7,086,379
$4.75M
opened
TOVX Theriva Biologics, Inc.
31 Oct 2006
Chief Executive Officer
Bought
35,431,896
no price
opened
15 decisions on file.